Cardiovascular Screening for the Asymptomatic Patient with Diabetes: More Cons Than Pros

Area of Science:

• Cardiology
• Endocrinology
• Preventive Medicine

Background:

• Diabetes mellitus significantly elevates the risk of coronary heart disease (CHD) morbidity and mortality.
• People with diabetes (PWD) often exhibit more aggressive and widespread coronary atherosclerosis, frequently asymptomatic.
• Diabetes independently increases cardiovascular disease (CVD) event risk, beyond other coexisting risk factors.

Purpose of the Study:

• To review the detection of coronary atherosclerosis and myocardial ischemia in asymptomatic PWD.
• To examine the management strategies for CHD in asymptomatic PWD.
• To address unresolved issues regarding ischemia extent and revascularization benefits in PWD.

Main Methods:

• Review of screening methods for silent myocardial ischemia in asymptomatic PWD.
• Analysis of randomized clinical trials on invasive revascularization procedures (PCI, CABG) in PWD.
• Evaluation of the impact of ischemia extent on risk and revascularization benefits.

Main Results:

• Screening for silent myocardial ischemia in asymptomatic PWD generally does not alter medical therapy.
• Aggressive preventive measures (BP, lipid control) are already indicated for PWD.
• Randomized trials have not demonstrated improved morbidity/mortality with invasive revascularization in asymptomatic PWD.

Conclusions:

• Current evidence suggests screening results for silent ischemia do not change management in most asymptomatic PWD.
• Optimal medical therapy remains the cornerstone for managing CHD risk in PWD.
• Further research is needed on the role of revascularization for moderate to severe ischemia in PWD.